SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-18-011542
Filing Date
2018-08-22
Accepted
2018-08-22 06:04:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D sc13d0818a3mtaglich_icagen.htm SC 13D/A 58116
  Complete submission text file 0001213900-18-011542.txt   59680
Mailing Address TAGLICH BROTHERS INC 1370 AVENUE OF THE AMERICAS --31ST FLOOR NEW YORK NY 6317254791
Business Address
TAGLICH MICHAEL N (Filed by) CIK: 0001024533 (see all company filings)

Type: SC 13D/A

Mailing Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703
Business Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703 919-941-5206
Icagen, Inc. (Subject) CIK: 0001518520 (see all company filings)

IRS No.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87457 | Film No.: 181031380
SIC: 8731 Services-Commercial Physical & Biological Research